A study published in Pediatrics suggests adolescent muscle weakness measured by grip strength is a predictor of unhealthy outcomes, including cardiovascular and metabolic diseases.

New research published in the Journal of the American Medical Association suggests stroke patients receive better care at teaching hospitals and have reduced rates of readmission during the early stages of their recovery.

New research published in The Lancet Neurology suggests four factors can help physicians predict whether intracerebral hemorrhage (ICH) patients are likely to experience further bleeding.

Patients with type 2 diabetes (T2D), who met target ranges for five particular cardiovascular risk factors, appeared to have little or no excess risk of death, myocardial infarction (MI) or stroke, according to a new study published Aug. 16 in the New England Journal of Medicine.

People with essential fructosuria, a rare genetic mutation, don’t have the enzyme needed to metabolize fructose, found in honey, fruits and vegetables. The benefit? Little to no risk of developing obesity or type 2 diabetes, reports Bloomberg.

Poor behavioral lifestyle is associated with incidences of cardiovascular disease (CVD) and diabetes within and across genetic risk groups, according to new research published in the Journal of the American Medical Association.

A new study published in European Heart Journal found patients with stable or controlled coronary artery disease (CAD) who have a diastolic blood pressure reading of 80-89 mmHg may have an increased risk for cardiovascular disease (CVD). A systolic blood pressure reading of 130-139 mmHg was not associated with an increased risk for CVD.

Normal daily doses of rivaroxaban (15 to 20 mg) are linked to triple the risk of intracerebral hemorrhage (ICH) when compared to aspirin, according to a meta-analysis of five randomized trials published Aug. 13 in JAMA Neurology.